TerminatedPhase 2

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation

NCT01955616

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

University of Southern California

Los Angeles, California, United States

+12 additional locations

Save this trial

University of Southern CaliforniaLos Angeles, California, United States
Colorado Neurological InstituteEnglewood, Colorado, United States
University of Florida Ctr for Movement Disorders & NeurorestorationGainesville, Florida, United States
Emory University, Wesley Woods Health CenterAtlanta, Georgia, United States
Georgia Regents UniversityAugusta, Georgia, United States
University of Iowa Hospitals, Movement Disorders Div, Dept of NeurologyIowa City, Iowa, United States
Michigan State UniversityEast Lansing, Michigan, United States
Henry Ford West Bloomfield HospitalWest Bloomfield, Michigan, United States
Atlantic NeuroscienceSummit, New Jersey, United States
University of RochesterRochester, New York, United States
University of Toledo Medical CenterToledo, Ohio, United States
Movement Disorders Program & The Parkinson's Center of OregonPortland, Oregon, United States
University of Pennsylvania, Penn Neurological InstitutePhiladelphia, Pennsylvania, United States